Advertisement
NeuroScientistNews
NeuroScientistNews

The Nutshell

» funding and cancer

Daily News Roundup

Most Recent

image: Surviving Acidity

Surviving Acidity

By | September 25, 2012

A new study reveals clues to the naked mole-rat’s ability to thrive in underground environments with high levels of carbon dioxide.

2 Comments

image: GM Crop Concerns

GM Crop Concerns

By | September 20, 2012

A questionable study claims that rats fed approved genetically modified maize developed cancer and died early.

13 Comments

image: Dotting “i”s and Crossing “t”s

Dotting “i”s and Crossing “t”s

By | September 17, 2012

As federal budgets tighten, the US government is getting serious about enforcing reporting and administrative rules that accompany academic grants.

2 Comments

image: Cantley Changes Jobs

Cantley Changes Jobs

By | September 14, 2012

Renowned cancer researcher Lewis Cantley is leaving Harvard to lead a new cancer center at Weill Cornell Medical College and NewYork-Presbyterian Hospital.

0 Comments

image: UK Ponies Up for Open Access

UK Ponies Up for Open Access

By | September 10, 2012

The United Kingdom government has devoted £10 million towards the goal of making all of the research it funds open access by next spring.

2 Comments

image: The NSF Shake-Up

The NSF Shake-Up

By | September 7, 2012

The federal agency is shuffling around its programs to streamline management and promote international scientific collaboration.

2 Comments

image: Funding Cuts Threaten Big Data

Funding Cuts Threaten Big Data

By | September 5, 2012

Reduced support from the US National Library of Medicine threatens to shut down five popular biological databases.

0 Comments

image: Orphan Drugs Lucrative

Orphan Drugs Lucrative

By | August 24, 2012

The market for drugs that target rare diseases is expected to rival big pharma blockbusters in the coming decades.

1 Comment

image: Review of NIH’s Big Hitters

Review of NIH’s Big Hitters

By | August 23, 2012

Proposals from researchers receiving more than $1 million a year in NIH funding will be carefully picked over to avoid overlap with ongoing research.

1 Comment

image: Court Rules Gene Patents Valid

Court Rules Gene Patents Valid

By | August 17, 2012

Myriad Genetics can hold patents on the BRAC1 and BRAC2 oncogenes, but not on tests comparing DNA sequences.

8 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement